Note 5 - Software Development Costs
|6 Months Ended|
Jun. 30, 2022
|Notes to Financial Statements|
|Research, Development, and Computer Software Disclosure [Text Block]||
5. Software Development Costs
The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities
The following table presents details of our software development costs as of June 30, 2022 and December 31, 2021:
Software development costs are being amortized on a straight-line basis over their estimated useful life ofyears.
Amortization expense for software development costs was $71,974 and $105,539 for the three months ended June 30, 2022 and 2021, respectively.
Amortization expense for software development costs was $145,263 and $204,748 for the six months ended June 30, 2022 and 2021, respectively.
The estimated future amortization expense of software development costs as of June 30, 2022 is as follows:
The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef